Members only

Allegra™ Overview

PASSION FOR OPTIMIZED PATIENT OUTCOMES


The heart is what keeps us going
It powers the body; it gives us life and energy. So does it fuel our commitment to address valvular heart disease as this can have a major impact on our wellbeing and be life-threatening.
We are passionate about learning and listening. Our success is based on working as partners with the medical and research communities. We aim to make the most of every therapeutic modality and to perfect minimally invasive cardiac valve therapies.
Those who are not able to undergo invasive surgery can then see their vitality restored and quality of life improved.



We are passionate about learning and listening
Our success is based on working as partners with the medical and research communities. We aim to make the most of every therapeutic modality and to perfect minimally invasive cardiac valve therapies.

We continuously learn from the vast surgical experience in treating valvular heart disease. We listen to physicians and engage in trusted dialogue with medical facilities to build a common understanding and nurture that passion for developing pioneering medical technology to create safe and cost-effective therapeutic approach.
 

11881-000-EN - Rev.04

CAUTION: Please note that the following pages are exclusively reserved for Health Care Professionals in countries with applicable health authority product registrations. To the extent this site contains information intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions. Please contact your Biosensors International representative for availability or the products and registration status.

The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology products, including BioMatrix NeoFlex™, BioMatrix™ Alpha, BioFreedom™, BioFreedom™ Ultra, Chroma™, BioStream™, BMX-J®, BioPath™, Powerline™, RISE™ NC, are not available for sale in the United States and certain other countries. ALLEGRA™ is a product of NVT AG. Blue Sail Medical Co., Ltd is the parent company of NVT AG and Biosensors International Group, Ltd. and its affliates are collaborating for the commercialization of the ALLEGRA™ device.

BioMatrix NeoFlex, BioMatrix Alpha, BioFreedom, BioFreedom Ultra, Chroma, BioStream, BMX-J, BioPath, Juno, S-Stent, Powerline, Rise NC and Quadrature Link are trademarks or registered trademarks of Biosensors International Group, Ltd. ALLEGRA is a trademark or registered trademark of NVT AG. ALLEGRA™ is CE Mark approved (CE 0124). All other cited trademarks are the property of their respective owners.